Pidotimod
Chemical compound
- L03AX05 (WHO)
- (4R)-3-(5-oxo-L-prolyl)-1,3-thiazolidine-4-carboxylic acid
- 121808-62-6 Y
- 65944
- 59348 Y
- 785363R681
- D07261 Y
- ChEMBL1488165 N
- DTXSID0046199
- Interactive image
- O=C(O)[C@H]2N(C(=O)[C@H]1NC(=O)CC1)CSC2
InChI
- InChI=1S/C9H12N2O4S/c12-7-2-1-5(10-7)8(13)11-4-16-3-6(11)9(14)15/h5-6H,1-4H2,(H,10,12)(H,14,15)/t5-,6-/m0/s1 Y
- Key:UUTKICFRNVKFRG-WDSKDSINSA-N Y
Pidotimod is an immunostimulant.[1]
References
- ^ Du XF, Jiang CZ, Wu CF, Won EK, Choung SY (September 2008). "Synergistic immunostimulating activity of pidotimod and red ginseng acidic polysaccharide against cyclophosphamide-induced immunosuppression". Archives of Pharmacal Research. 31 (9): 1153–9. doi:10.1007/s12272-001-1282-6. PMID 18806958. S2CID 207408882.
- v
- t
- e
Immunostimulants (L03)
Cytokines |
| ||||||
---|---|---|---|---|---|---|---|
Other protein / peptide | |||||||
Other |
- beta-glucan
- heterocyclic compound
- hydroxyquinoline
- Mifamurtide
- oligopeptides
- polyribonucleotide
- Polyinosinic:polycytidylic acid
- thiazolidine
- Pidotimod
- Inosine pranobex
- vaccines
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e